Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4063965

NCCN1C(=O)C(C(N)=O)Cc2ccccc21.O=C(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
F2 P00734 2/20 0.38
PRSS1 P07477 1/20 0.38
AADAT Q8N5Z0 2/20 0.37
GOT1 P17174 1/20 0.37
KYAT1 Q16773 1/20 0.37
KYAT3 Q6YP21 1/20 0.37
CACNA1S Q13698 1/20 0.37
ACE P12821 1/20 0.37
HTR2A P28223 1/20 0.36
CHRM2 P08172 2/20 0.35
CHRM4 P08173 2/20 0.35
CHRM1 P11229 2/20 0.35
SCN9A Q15858 1/20 0.35
CHRM5 P08912 1/20 0.35
CHRM3 P20309 1/20 0.35
F7 P08709 1/20 0.35
F3 P13726 1/20 0.35
ALDH1A1 P00352 1/20 0.35
PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4063967 0.87 AADAT (0.50) F2PRSS1AADATGOT1KYAT1
SCHEMBL4064970 0.82 PYGL (0.44) AADATGOT1KYAT1KYAT3CACNA1S
SCHEMBL4242431 0.80 PYGL (0.46) AADATGOT1KYAT1KYAT3HTR2A
SCHEMBL4073069 0.78 PYGL (0.47) AADATGOT1KYAT1KYAT3CACNA1S
SCHEMBL4064393 0.77 PYGL (0.48) AADATGOT1KYAT1KYAT3CACNA1S
SCHEMBL4069784 0.76 ALDH1A1 (0.38) AADATGOT1KYAT1KYAT3CACNA1S
SCHEMBL4067574 0.75 PYGL (0.46) AADATGOT1KYAT1KYAT3ACE
SCHEMBL4064399 0.74 MTNR1A (0.42) AADATGOT1KYAT1KYAT3ALDH1A1
SCHEMBL4067680 0.74 PYGL (0.36) AADATGOT1KYAT1KYAT3CACNA1S
SCHEMBL4064789 0.73 POLB (0.47) AADATGOT1KYAT1KYAT3ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099176-A1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES PROSIDION LIMITED (GB) 2009-04-16 US disclosed
EP-1819332-B1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES PROSIDION LTD (GB) 2009-03-11 EP disclosed
EP-1819332-A2 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES Prosidion Limited (GB) 2007-08-22 EP disclosed
WO-2006059164-A2 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES PROSIDION LIMITED (GB) 2006-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099176-A1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES PC, GOT2, PDK1 F2 1249/4885PRSS1 1779/4885AADAT 426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.